阿摩線上測驗 登入

試題詳解

試卷:112年 - 112 消化系內科專科醫師甄審試題#131327 | 科目:消化系內科專科醫師

試卷資訊

試卷名稱:112年 - 112 消化系內科專科醫師甄審試題#131327

年份:112年

科目:消化系內科專科醫師

77. 依據 BCLC 2022 update,下列何者正確?
(1) For solitary HCC, the presence of CSPH (defined by a hepatic venous
pressure gradient [HVPG] > 10 mmHg) is the key consideration to decide
treatment option
(2) BCLC A is defined as solitary HCC irrespective of size or as a multifocalHCC up to 3 nodules (none of them > 3 cm), without macrovascular invasion, extrahepatic spread or cancer-related symptoms
(3) The 2022 version of the BCLC staging system does not recommend
resection for multinodular HCC within Milan criteria
(4) MW (microwave) achieves more extensive tumour necrosis than RF
(radiofrequency) and is potentially the best option for those patients with
HCC > 4 cm
(A) (1)
(B) (1)+(2)
(C) (2)+(3)
(D) (1)+(2)+(3)

(E) (1)+(2)+(3)+(4)
正確答案:登入後查看

詳解 (共 1 筆)

推薦的詳解#6814653
未解鎖
1. 題目解析 這道考題是關於肝細胞癌(...
(共 1040 字,隱藏中)
前往觀看
0
0